Drug intelligence / Profile preview

cystamine

Development stage
Preclinical
Lead developer
Chiesi
Modality
Small Molecules
Administration
Intraperitoneal, Intravenous, Oral
01

Overview

Cystamine is a low-molecular-weight thiol and the oxidized disulfide form of cysteamine. It has been studied primarily as an experimental agent, in part for its ability to inhibit transglutaminase enzymes and modulate redox status. Cystamine can also increase intracellular levels of cysteine and has demonstrated neuroprotective properties in various preclinical models, including models of neurodegenerative diseases such as Huntington's disease and Parkinson's disease. The principal mechanism involves modulation of cysteine metabolism and inhibition of transglutaminase. Cystamine itself is not approved as a pharmaceutical drug for any indication, but its reduced form (cysteamine) is approved and widely used, especially in nephropathic cystinosis[4].

Other names
2,2'-dithiobis(ethylamine)cystamine dihydrochloride
02

Targets

TGM2 (Tissue Transglutaminase 2)

Beyond the preview

Go deeper on cystamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cystamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call